Medclair AB (publ.) (NGM:MCLR)

Market Cap	224.54M -9.9%
Revenue (ttm)	57.70M +17.1%
Net Income	382.00K -92.7%
EPS	n/a
Shares Out	91.65M
PE Ratio	587.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400,978
Open	n/a
Previous Close	2.600
Day's Range	n/a
52-Week Range	2.200 - 3.120
Beta	0.73
Analysts	n/a
Price Target	n/a
Est. Earnings	Feb 18, 2027

About Medclair AB (publ.)

Medclair AB (publ.), a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O) in Sweden. It offers mobile destruction unit, a mobile unit that enables the destruction of nitrous oxide; central destruction unit, an ideal solution for situations where Nitrous Oxide (N2O) is used simultaneously in multiple treatment rooms; Recycling Decomposition Unit, an intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O canisters and decomposes it within a self-suppo...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 21
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error